Type 2 Inflammation in COPD
COPD is a chronic, heterogeneous, and often progressive inflammatory airway disease that leads to reduced health-related quality of life in patients. Discover more about COPD with type 2 inflammation through a broad selection of medical resources.
- Review the pathophysiologic processes underlying COPD and its clinical consequences
- Understand the complexity and heterogeneous inflammatory pathways involved in COPD
- Gain insights into the burden of type 2 inflammation in COPD patients
- Learn about the key differences between asthma and COPD
of interest
are looking at
saved
next event
Developed by EPG Health for Medthority in collaboration with Sanofi and Regeneron, with content provided by Sanofi and Regeneron. ADVENT is a medical education non-promotional program for healthcare professionals organized by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals.
© 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
MAT-US-2405120 V1.0 – P Exp Date: 06/11/2026.
Sanofi and Regeneron are committed to providing resources to advance knowledge in areas of unmet medical need among patients with inflammatory and immunologic diseases.